AcquisitionOther
FoxWayne Enterprises Acquisition Corp. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
FoxWayne Enterprises Acquisition Corp. -> target · $250 million
to Become Public Company New entity poised to accelerate the development of Aerami's diverse pipeline of next-generation inhaled therapies AER-901, Aerami's proprietary inhaled, nebulized formulation of imatinib, targeted to advance in 2022 into a Phase 2/3 cl
Open source record (SEC) ↗